This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Sterile Compounding Pharmacies Market

Sterile Compounding Pharmacies Market

Sterile Compounding Pharmacies Market Growth to Spur with Rising Demand for Injectables during 2021-2031

Sterile Compounding Pharmacies Market
FACT7061MR
  • Oct-2021
  • List of Tables : 24
  • List of Figures : 135
  • 170 Pages
  • Healthcare

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Wheel of Fortune

    1.3. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions/Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Industry Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Rising prevalence of chronic disease

        4.2.2. Increasing capital investment

        4.2.3. Rise in demand for compounded medication

        4.2.4. Increasing investment towards expansion of the healthcare infrastructure

        4.2.5. New product launches 

        4.2.6. Regulatory dynamics

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. Key Success Factors

    5.1. Product Consumption By Region

    5.2. Key Regulations

    5.3. PEST Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. COVID19 and Impact Analysis

        6.3.1. Revenue By Product

        6.3.2. Revenue By Therapeutic Area

        6.3.3. Revenue By End User

        6.3.4. Revenue By Country

    6.4. 2020 Market Scenario

    6.5. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016 – 2020 and Forecast, 2021 – 2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016 – 2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021 – 2031

        7.2.1.  Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product

    8.1. Introduction / Key Findings 

    8.2. Historical Market Value (US$ Mn) Analysis By Product, 2016 – 2020

    8.3. Current Market Value (US$ Mn) Analysis and Forecast By Product, 2021 – 2031

        8.3.1. Injectable

        8.3.2. Nasal

        8.3.3. Ocular

        8.3.4. Otic

    8.4. Market Attractiveness Analysis By Product

9. Global Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By Therapeutic Area

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Analysis By Therapeutic Area, 2016 – 2020

    9.3. Current Market Value (US$ Mn) Analysis and Forecast By Therapeutic Area, 2021 – 2031

        9.3.1. Hormone Replacement Therapy

        9.3.2. Pain Management

        9.3.3. Dermatology

        9.3.4. Oncology

        9.3.5. Hematology

        9.3.6. Dental

        9.3.7. Others

    9.4. Market Attractiveness Analysis By Therapeutic Area

10. Global Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) Analysis By End User, 2016 – 2020

    10.3. Current Market Value (US$ Mn) Analysis and Forecast By End User, 2021 – 2031

        10.3.1. Adults

        10.3.2. Pediatrics

        10.3.3. Geriatrics

        10.3.4. Veterinary

    10.4. Market Attractiveness Analysis By End User

11. Global Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By Region

    11.1. Introduction

    11.2. Historical Market Value (US$ Mn) Analysis By Region, 2016 – 2020

    11.3. Current Market Value (US$ Mn) Analysis Forecast By Region, 2021 – 2031

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    12.1. Introduction

    12.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016 – 2020

    12.3. Current Market Value (US$ Mn) Analysis Forecast By Market Taxonomy , 2021 – 2031

        12.3.1.  By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Product

        12.3.3. By Therapeutic Area

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    13.1. Introduction

    13.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016 – 2020

    13.3. Current Market Value (US$ Mn) Analysis Forecast By Market Taxonomy , 2021 – 2031

        13.3.1.  By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Product

        13.3.3. By Therapeutic Area

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    14.1. Introduction

    14.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016 – 2020

    14.3. Current Market Value (US$ Mn) Analysis Forecast By Market Taxonomy , 2021 – 2031

        14.3.1.  By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. Russia

            14.3.1.7. Rest of Europe

        14.3.2. By Product

        14.3.3. By Therapeutic Area

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Asia Pacific Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    15.1. Introduction

    15.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016 – 2020

    15.3. Current Market Value (US$ Mn) Analysis Forecast By Market Taxonomy , 2021 – 2031

        15.3.1.  By Country

            15.3.1.1. Australia & New Zealand

            15.3.1.2. Singapore

            15.3.1.3. China

            15.3.1.4. India

            15.3.1.5. Rest of Asia Pacific

        15.3.2. By Product

        15.3.3. By Therapeutic Area

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Sterile Compounding Pharmacies Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    16.1. Introduction

    16.2. Historical Market Value (US$ Mn) Analysis By Market Taxonomy, 2016 – 2020

    16.3. Current Market Value (US$ Mn) Analysis Forecast By  Market Taxonomy , 2021 – 2031

        16.3.1.  By Country

            16.3.1.1. Saudi Arabia

            16.3.1.2. South Africa

            16.3.1.3. Rest of Middle East and Africa

        16.3.2. By Product

        16.3.3. By Therapeutic Area

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Key and Emerging Countries Sterile Compounding Pharmacies Market Analysis 2021 & 2031

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. U.S. Sterile Compounding Pharmacies Market Value Analysis

        17.2.1. By Product

        17.2.2. By Therapeutic Area

        17.2.3. By End User

    17.3. Canada Sterile Compounding Pharmacies Market Analysis

        17.3.1. By Product

        17.3.2. By Therapeutic Area

        17.3.3. By End User

    17.4. Mexico Sterile Compounding Pharmacies Market Value Analysis

        17.4.1. By Product

        17.4.2. By Therapeutic Area

        17.4.3. By End User

    17.5. Brazil Sterile Compounding Pharmacies Market Value Analysis

        17.5.1. By Product

        17.5.2. By Therapeutic Area

        17.5.3. By End User

    17.6. U.K. Sterile Compounding Pharmacies Market Value Analysis

        17.6.1. By Product

        17.6.2. By Therapeutic Area

        17.6.3. By End User

    17.7. Germany Sterile Compounding Pharmacies Market Analysis

        17.7.1. By Product

        17.7.2. By Therapeutic Area

        17.7.3. By End User

    17.8. France Sterile Compounding Pharmacies Market Analysis

        17.8.1. By Product

        17.8.2. By Therapeutic Area

        17.8.3. By End User

    17.9. Netherland Sterile Compounding Pharmacies Market Analysis

        17.9.1. By Product

        17.9.2. By Therapeutic Area

        17.9.3. By End User

    17.10. Italy Sterile Compounding Pharmacies Market Analysis

        17.10.1. By Product

        17.10.2. By Therapeutic Area

        17.10.3. By End User

    17.11. Spain Sterile Compounding Pharmacies Market Analysis

        17.11.1. By Product

        17.11.2. By Therapeutic Area

        17.11.3. By End User

    17.12. Australia and New Zealand Sterile Compounding Pharmacies Market Analysis

        17.12.1. By Product

        17.12.2. By Therapeutic Area

        17.12.3. By End User

    17.13. Singapore Sterile Compounding Pharmacies Market Analysis

        17.13.1. By Product

        17.13.2. By Therapeutic Area

        17.13.3. By End User 

    17.14. China Sterile Compounding Pharmacies Market Value Analysis

        17.14.1. By Product

        17.14.2. By Therapeutic Area

        17.14.3. By End User

    17.15. India Sterile Compounding Pharmacies Market Analysis

        17.15.1. By Product

        17.15.2. By Therapeutic Area

        17.15.3. By End User

    17.16. Saudi Arabia Sterile Compounding Pharmacies Market Analysis

        17.16.1. By Product

        17.16.2. By Therapeutic Area

        17.16.3. By End User

    17.17. South Africa Sterile Compounding Pharmacies Market Analysis

        17.17.1. By Product

        17.17.2. By Therapeutic Area

        17.17.3. By End User

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies 

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Deep Dive 

        19.2.1. Fagron

            19.2.1.1. Overview

            19.2.1.2. Product Portfolio

            19.2.1.3. Profitability by Market Segments (Product/End User/Region)

            19.2.1.4. Sales Footprint

            19.2.1.5. Strategy Overvie

        19.2.2. Fresenius Kabi AG 

            19.2.2.1. Overview

            19.2.2.2. Product Portfolio

            19.2.2.3. Profitability by Market Segments (Product/End User/Region)

            19.2.2.4. Sales Footprint

            19.2.2.5. Strategy Overvie

        19.2.3. PharMEDium Services, LLC 

            19.2.3.1. Overview

            19.2.3.2. Product Portfolio

            19.2.3.3. Profitability by Market Segments (Product/End User/Region)

            19.2.3.4. Sales Footprint

            19.2.3.5. Strategy Overvie

        19.2.4. Institutional Pharmacy Solutions 

            19.2.4.1. Overview

            19.2.4.2. Product Portfolio

            19.2.4.3. Profitability by Market Segments (Product/End User/Region)

            19.2.4.4. Sales Footprint

            19.2.4.5. Strategy Overvie

        19.2.5. Cantrell Drug Company 

            19.2.5.1. Overview

            19.2.5.2. Product Portfolio

            19.2.5.3. Profitability by Market Segments (Product/End User/Region)

            19.2.5.4. Sales Footprint

            19.2.5.5. Strategy Overvie

        19.2.6. Lorraine’s Pharmacy 

            19.2.6.1. Overview

            19.2.6.2. Product Portfolio

            19.2.6.3. Profitability by Market Segments (Product/End User/Region)

            19.2.6.4. Sales Footprint

            19.2.6.5. Strategy Overvie

        19.2.7. B. Braun Melsungen AG Company.

            19.2.7.1. Overview

            19.2.7.2. Product Portfolio

            19.2.7.3. Profitability by Market Segments (Product/End User/Region)

            19.2.7.4. Sales Footprint

            19.2.7.5. Strategy Overvie

20. Assumptions and Acronyms Used

21. Research Methodology

Know More Details About the Report

List of Tables

Table 01: Global Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 02: Global Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area

Table 03: Global Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 04: Global Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 05: North America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 06: North America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 07: North America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area

Table 08: North America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 09: Latin America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 10: Latin America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 11: Latin America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area

Table 12: Latin America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 13: Europe Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 14: Europe Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 15: Europe Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area

Table 16: Europe Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 17: Asia Pacific Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 18: Asia Pacific Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 19: Asia Pacific Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area

Table 20: Asia Pacific Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 21: MEA Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 22: MEA Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 23: MEA Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area

Table 24: MEA Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Have a report related query? Speak to us directly

List of Figures

Figure 01: Global Compounding Pharmacies Market Split By Product, 2021 (E)

Figure 02: Global Compounding Pharmacies Market Split By Therapeutic Area, 2021 (E)

Figure 03: Global Compounding Pharmacies Market Split By End User, 2021 (E)

Figure 04: Global Compounding Pharmacies Market Split By Region, 2021 (E)

Figure 05: Global Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis, 2016-2020

Figure 06: Global Sterile Compounding Pharmacies Market Value (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 07: Global Sterile Compounding Pharmacies Market Incremental $ Opportunity, 2021-2031

Figure 08: Sterile Compounding Pharmacies Market Analysis, By Product –2021 & 2031

Figure 09: Sterile Compounding Pharmacies Market Y-o-Y Growth Projections, By Product 2021 – 2031

Figure 10: Global Sterile Compounding Pharmacies Market Attractiveness Analysis 2016-2020 and Forecast 2021-2031, By Product

Figure 11: Global Sterile Compounding Pharmacies Market Analysis, By End User –2021 & 2031

Figure 12: Global Sterile Compounding Pharmacies Market Y-o-Y Growth Projections By End User, 2021 – 2031

Figure 13: Global Sterile Compounding Pharmacies Market Attractiveness Analysis 2016-2020 and Forecast 2021-2031, By Therapeutic Area

Figure 14: Global Sterile Compounding Pharmacies Market Analysis, By End User –2021 & 2031

Figure 15: Global Sterile Compounding Pharmacies Market Y-o-Y Growth Projections, By End User, 2021 – 2031

Figure 16: Global Sterile Compounding Pharmacies Market Attractiveness Analysis 2016-2020 and Forecast 2021-2031, By End User

Figure 17: Global Sterile Compounding Pharmacies Market Analysis, By Region–2021 & 2031

Figure 18: Global Sterile Compounding Pharmacies Market Y-o-Y Growth Projections, By Region 2021 – 2031

Figure 19: Global Sterile Compounding Pharmacies Market Attractiveness Analysis 2016-2020 and Forecast 2021-2031, By Region

Figure 20: North America Sterile Compounding Pharmacies Market Analysis, By Product (2021E)

Figure 21: North America Sterile Compounding Pharmacies Market Analysis, By Therapeutic Area (2021E)

Figure 22: North America Sterile Compounding Pharmacies Market Analysis, By Country (2021E)

Figure 23: North America Sterile Compounding Pharmacies Market Analysis, By End User (2021E)

Figure 24: North America Sterile Compounding Pharmacies Market Value (US$ Mn), Historical, 2016-2020

Figure 25: North America Sterile Compounding Pharmacies Market Value (US$ Mn), Forecast, 2021-2031

Figure 26: North America Sterile Compounding Pharmacies Market Attractiveness Analysis by Product, 2021-2031

Figure 27: North America Sterile Compounding Pharmacies Market Attractiveness Analysis by Therapeutic Area, 2021-2031

Figure 28: North America Sterile Compounding Pharmacies Market Attractiveness Analysis by End User, 2021-2031

Figure 29: North America Sterile Compounding Pharmacies Market Attractiveness Analysis by Country, 2021-2031

Figure 30: Latin America Sterile Compounding Pharmacies Market Analysis, By Product (2021E)

Figure 31: Latin America Sterile Compounding Pharmacies Market Analysis, By Therapeutic Area (2021E)

Figure 32: Latin America Sterile Compounding Pharmacies Market Analysis, By Country (2021E)

Figure 33: Latin America Sterile Compounding Pharmacies Market Analysis, By End User (2021E)

Figure 34: Latin America Sterile Compounding Pharmacies Market Value (US$ Mn) Analysis, Historical, 2016-2020

Figure 35: Latin America Sterile Compounding Pharmacies Market Value (US$ Mn), Forecast, 2021-2031

Figure 36: Latin America Sterile Compounding Pharmacies Market Attractiveness Analysis by Product, 2021-2031

Figure 37: Latin America Sterile Compounding Pharmacies Market Attractiveness Analysis by Therapeutic Area, 2021-2031

Figure 38: Latin America Sterile Compounding Pharmacies Market Attractiveness Analysis by End User, 2021-2031

Figure 39: Latin America Sterile Compounding Pharmacies Market Attractiveness Analysis by Country, 2021-2031

Figure 40: Europe Sterile Compounding Pharmacies Market Analysis, By Product (2021E)

Figure 41: Europe Sterile Compounding Pharmacies Market Analysis, By Therapeutic Area (2021E)

Figure 42: Europe Sterile Compounding Pharmacies Market Analysis, By Country (2021E)

Figure 43: Europe Sterile Compounding Pharmacies Market Analysis, By End User (2021E)

Figure 44: Europe Sterile Compounding Pharmacies Market Value (US$ Mn), Historical, 2016-2020

Figure 45: Europe Sterile Compounding Pharmacies Market Value (US$ Mn), Forecast, 2021-2031

Figure 46: Europe Sterile Compounding Pharmacies Market Attractiveness Analysis by Product, 2021-2031

Figure 47: Europe Sterile Compounding Pharmacies Market Attractiveness Analysis by Therapeutic Area, 2021-2031

Figure 48: Europe Sterile Compounding Pharmacies Market Attractiveness Analysis by End User, 2021-2031

Figure 49: Europe Sterile Compounding Pharmacies Market Attractiveness Analysis by Country, 2021-2031

Figure 50: Asia Pacific Sterile Compounding Pharmacies Market Analysis, By Product (2021E)

Figure 51: Asia Pacific Sterile Compounding Pharmacies Market Analysis, By Therapeutic Area (2021E)

Figure 52: Asia Pacific Sterile Compounding Pharmacies Market Analysis, By Country (2021E)

Figure 53: Asia Pacific Sterile Compounding Pharmacies Market Analysis, By End User (2021E)

Figure 54: Asia Pacific Sterile Compounding Pharmacies Market Value (US$ Mn), Historical, 2016-2020

Figure 55: Asia Pacific Sterile Compounding Pharmacies Market Value (US$ Mn), Forecast, 2021-2031

Figure 56: Asia Pacific Sterile Compounding Pharmacies Market Attractiveness Analysis by Product, 2021-2031

Figure 57: Asia Pacific Sterile Compounding Pharmacies Market Attractiveness Analysis by Therapeutic Area, 2021-2031

Figure 58: Asia Pacific Sterile Compounding Pharmacies Market Attractiveness Analysis by End User, 2021-2031

Figure 59: Asia Pacific Sterile Compounding Pharmacies Market Attractiveness Analysis by Country, 2021-2031

Figure 60: MEA Sterile Compounding Pharmacies Market Analysis, By Product (2021E)

Figure 61: MEA Sterile Compounding Pharmacies Market Analysis, By Therapeutic Area (2021E)

Figure 62: MEA Sterile Compounding Pharmacies Market Analysis, By Country (2021E)

Figure 63: MEA Sterile Compounding Pharmacies Market Analysis, By End User (2021E)

Figure 64: MEA Sterile Compounding Pharmacies Market Value (US$ Mn), Historical, 2016-2020

Figure 65: MEA Sterile Compounding Pharmacies Market Value (US$ Mn), Forecast, 2021-2031

Figure 66: MEA Sterile Compounding Pharmacies Market Attractiveness Analysis by Product, 2021-2031

Figure 67: MEA Sterile Compounding Pharmacies Market Attractiveness Analysis by Therapeutic Area, 2021-2031

Figure 68: MEA Sterile Compounding Pharmacies Market Attractiveness Analysis by End User, 2021-2031

Figure 69: MEA Sterile Compounding Pharmacies Market Attractiveness Analysis by Country, 2021-2031

Figure 70: Global Sterile Compounding Pharmacies Market Value Proportion Analysis, By Countries, 2021

Figure 71: Global Sterile Compounding Pharmacies Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2021-2031

Figure 72: U.S Sterile Compounding Pharmacies Market Share Analysis (%), By Product, 2021 & 2031

Figure 73: U.S Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 74: U.S Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 75: Global Vs. U.S Growth Comparison

Figure 76: Canada Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 77: Canada Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 78: Canada Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 79: Global Vs. Canada Growth Comparison

Figure 80: Mexico Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 81: Mexico Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 82: Mexico Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 83: Global Vs. Mexico Growth Comparison

Figure 84: Brazil Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 85: Brazil Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 86: Brazil Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 87: Global Vs. Brazil Growth Comparison

Figure 88: U.K. Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 89: U.K. Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 90: U.K. Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 91: Global Vs. U.K. Growth Comparison

Figure 92: Germany Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 93: Germany Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 94: Germany Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 95: Global Vs. Germany Growth Comparison

Figure 96: France Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 97: France Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 98: France Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 99: Global Vs. France Growth Comparison

Figure 100: Netherland Sterile Compounding Pharmacies Market Share Analysis (%), By Product, 2021 & 2031

Figure 101: Netherland Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 102: Netherland Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 103: Global Vs. Netherland Growth Comparison

Figure 104: Italy Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 105: Italy Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 106: Italy Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 107: Global Vs. Italy Growth Comparison

Figure 108: Spain Sterile Compounding Pharmacies Market Share Analysis (%), By Product, 2021 & 2031

Figure 109: Spain Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 110: Spain Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 111: Global Vs. Spain Growth Comparison

Figure 112: Australia and New Zealand  Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 113: Australia and New Zealand  Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 114: Australia and New Zealand Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 115: Global Vs. U.S Growth Comparison

Figure 116: Singapore Sterile Compounding Pharmacies Market Share Analysis (%), By Product,  2021 & 2031

Figure 117: Singapore Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 118: Singapore Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 119: Global Vs. Singapore Growth Comparison

Figure 120: China Sterile Compounding Pharmacies Market Share Analysis (%), By Product, 2021 & 2031

Figure 121: China Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 122: China Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 123: Global Vs. China Growth Comparison

Figure 124: India Sterile Compounding Pharmacies Market Share Analysis (%), By Product, 2021 & 2031

Figure 125: India Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 126: India Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 127: Global Vs. India Growth Comparison

Figure 128: Saudi Arabia Sterile Compounding Pharmacies Market Share Analysis (%), By Product, 2021 & 2031

Figure 129: Saudi Arabia Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 130: Saudi Arabia  Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 131: Global Vs. Saudi Arabia  Growth Comparison

Figure 132: South Africa Sterile Compounding Pharmacies Market Share Analysis (%), By Product, 2021 & 2031

Figure 133: South Africa Sterile Compounding Pharmacies Market Share Analysis (%), By Therapeutic Area, 2021 & 2031

Figure 134: South Africa Sterile Compounding Pharmacies Market Share Analysis (%), By End User, 2021 & 2031

Figure 135: Global Vs. South Africa Growth Comparison

Sterile Compounding Pharmacies Market - Scope of Report

A latest publication by Fact.MR on the sterile compounding pharmacies market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, including Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Fact.MR's study. This research study can support readers to know the demand for sterile compounding pharmacies products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the market, including investors, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in this space. Insights and analysis presented in this Fact.MR study can be leveraged by shareholders in the market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the sterile compounding pharmacies market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the sterile compounding pharmacy industry can be aided in making suitable company choices to achieve traction in the market.

Key Questions Answered in Report

  • Which geographic regions will continue to remain most profitable markets for sterile compounding pharmacies?
  • Which parameters will bring a change in demand for sterile compounding pharmacies during the forecast period?
  • How will changing trends impact the market?
  • How will the COVID-19 pandemic impact market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the sterile compounding pharmacies market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can businesses in the market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the sterile compounding pharmacies market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the study include statistics from governmental organizations, trade journals, white papers, internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Fact.MR’s projections on the growth prospects of the sterile compounding pharmacies market more accurate and reliable.

- FAQs -

At present, the global sterile compounding pharmacies market is worth US$ 4.2 Bn.

Sales of injections are expected to top US$ 5.3 Bn by the end of 2031, with revenue expected to register a CAGR of 6% over the same period.

From 2016-2020, the market expanded at the rate of 5.8%, owing to growing demand for compounded formulations.

Diversification of services, increasing FDA compliance, changing pharmacy store formats, increasing mergers & acquisitions by leading players, new product launches, and approvals are some of the key trends shaping market expansion.

The U.S., Canada, Australia & New Zealand, Singapore, and U.K. are expected to drive most demand for sterile compounding pharmacies over the next ten years.

North America is a key market for sterile compounding pharmacies, with the U.S. expected to account for 72% regional market share through 2031.

Demand for sterile compounding pharmacies in Europe is expected to register a growth rate of 7.6% CAGR through the decade.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Medical Education Market

The medical education market is anticipated to experience moderate growth in the forecast period (20...

Antibiotic-loaded Bone Cement Market

Antibiotic-loaded Bone Cement Market to grow at a healthy CAGR during the forecast period, 2018-2026...

Carotid Stenting Systems Market

Carotid Stenting Systems Market research report covers detailed information on Global Carotid Stenti...

Peripheral Artery Revascularisation Market

Peripheral Artery Revascularisation Market is set to witness steady growth during 2018-2028. Stents ...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.